Interventional management in a heart failure patient | 58742
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

Interventional management in a heart failure patient

Joint Meeting on 7th International Conference on Hypertension and Healthcare & 29th International Conference on Cardiology and Healthcare

June 10-11, 2019 Helsinki, Finland

Corneliu Iorgulescu

Inter Cardio Clinique, Romania

Scientific Tracks Abstracts: J Clin Exp Cardiolog

Abstract :

Case Report: We present the case of 72 years male; diabetic, hypertensive with ischemic cardiomyopathy, moderate-severe mitral regurgitation and left bundle branch block. At the initial hospitalization the patient had a 25% LVEF and was NYHA 4 with optimal medical therapy- ACE inhibitor, Beta-blocker, Spironolactone and Furosemide. He had trivascular coronary heart disease with complete interventional revascularization. A CRT-D was implanted with an increase of LVEF at 35% to 40% at six months and NYHA class II symptoms. After two years he developed atrial fibrillation and NYHA class III symptoms. Amiodarone was attempted unsuccessfully so after six months a pulmonary veins isolation procedure was performed. The patient remained in sinus rhythm and NYHA II for one year than atrial fibrillation reoccurred. At that moment he was NYHA III with optimal medical therapy, LVEF was 35% with severe mitral regurgitation. The patient was proposed for mitral clip implant and he was switched to Sacubitril/Valsartan therapy. He improved to NYHA II class and remained stable for two years. No mitral clip was implanted.

Biography :

Career Performance Professional Training: - Graduate of UMF Carol Davila Bucharest 2003 - Cardiology Specialist 2010 -Examen European Competence of Implantable Cardiac Devices 2008 -Examen European Electrophysiology Competence 2012 - Europhysiology Training Course 2011-2012 in Hungary, Szeged - Romanian Society of Cardiology extraction of implantable cardiac devices in Italy, Pisa - 2016 Performed procedures: - Cardiac simulators - Resynchronization therapy - Cardiac defibrillators - Standard radiofrequency abrasions - 3D assisted radiofrequency assemblies - Implanted cardiac extractions.